BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 20078968)

  • 1. [Clinicopathologic study of centrally necrotizing carcinoma of breast].
    Yu L; Yang WT; Cai X; Lu HF; Fan YZ; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):657-62. PubMed ID: 20078968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Centrally necrotizing carcinoma of the breast: clinicopathological analysis of 33 cases indicating its basal-like phenotype and poor prognosis.
    Yu L; Yang W; Cai X; Shi D; Fan Y; Lu H
    Histopathology; 2010 Aug; 57(2):193-201. PubMed ID: 20716161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological study of centrally necrotizing carcinoma of the breast.
    Zhang Y; Ou Y; Yu D; Yong X; Wang X; Zhu B; Zhang Q; Zhou L; Cai Z; Cheng Z
    BMC Cancer; 2015 Apr; 15():282. PubMed ID: 25880163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathologic features and immunohistochemistry of the basal-like subtype of invasive breast carcinoma].
    Liu LP; Bai J; Wei Y; Qi XD; Si TC; Li W; Pan H
    Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):101-5. PubMed ID: 23710916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal-like immunophenotype markers and prognosis in early breast cancer.
    Cassol L; Silveira Graudenz M; Zelmanowicz A; Cancela A; Werutsky G; Rovere RK; Garicochea B
    Tumori; 2010; 96(6):966-70. PubMed ID: 21388060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathologic study of solid papillary carcinoma of breast].
    Wei B; Bu H; Chen HJ; Zhang HY; Li XJ
    Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):589-93. PubMed ID: 17134565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathologic features and prognostic significance of basal-like breast cancer].
    Liu H; Fan QH; Li X; Liu GZ
    Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):316-22. PubMed ID: 19575874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Solid variant of mammary adenoid cystic carcinoma with basaloid features: a clinicopathologic and immunohistochemical study].
    Zhou RJ; Hu CY; Yu L; Bi R; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):803-7. PubMed ID: 23324227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morphological features of basal-like subtype invasive carcinoma of breast].
    Gao LX; Yang GZ; Ding HY; Li L
    Zhonghua Bing Li Xue Za Zhi; 2008 Feb; 37(2):83-7. PubMed ID: 18681317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Roles of immunohistochemistry in prognostic assessment of basal-like breast cancer].
    Liu H; Fan QH; Zhang ZH; Li X; Yu HP; Liu GZ; Meng FQ
    Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):23-8. PubMed ID: 19489221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inference of the Basal epithelial phenotype in breast carcinoma from differential marker expression, using tissue microarrays in triple negative breast cancer and women younger than 35.
    Nassar A; Sussman ZM; Lawson D; Cohen C
    Breast J; 2012 Sep; 18(5):399-405. PubMed ID: 22882580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between breast cancer molecular subtypes with clinicopathological characteristics and prognosis].
    Lin M; Chen ZQ; Bao Y; Li Q; Du ZG; Xu ZD; Tang F
    Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):372-6. PubMed ID: 21055152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrotic focus in breast carcinomas: relationship with prognostic parameters and biomarkers.
    Mujtaba SS; Ni YB; Tsang JY; Chan SK; Yamaguchi R; Tanaka M; Tan PH; Tse GM
    Ann Surg Oncol; 2013 Sep; 20(9):2842-9. PubMed ID: 23539156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathologic features of cystic hypersecretory lesion of the breast].
    Bi R; Cheng Y; Yu B; Shui R; Yang W; Xu X
    Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):25-9. PubMed ID: 24713245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of CK5/6 and CK17 and its correlation with prognosis of triple-negative breast cancer patients].
    Liu ZB; Wu J; Ping B; Feng LQ; Shen ZZ; Shao ZM
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):610-4. PubMed ID: 19102940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic features of breast carcinomas classified by biomarkers and correlation with microvessel density and VEGF expression: a study from Thailand.
    Chuangsuwanich T; Pongpruttipan T; O-Charoenrat P; Komoltri C; Watcharahirun S; Sa-Nguanraksa D
    Asian Pac J Cancer Prev; 2014; 15(3):1187-92. PubMed ID: 24606439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.
    Kim MJ; Ro JY; Ahn SH; Kim HH; Kim SB; Gong G
    Hum Pathol; 2006 Sep; 37(9):1217-26. PubMed ID: 16938528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Centrally necrotizing carcinomas of the breast: a distinct histologic subtype with aggressive clinical behavior.
    Jimenez RE; Wallis T; Visscher DW
    Am J Surg Pathol; 2001 Mar; 25(3):331-7. PubMed ID: 11224603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.